Research paper
Murine mucosal T cells have VIP receptors functionally distinct from those on intestinal epithelial cells

https://doi.org/10.1016/0165-5728(92)90179-OGet rights and content

Abstract

Reports suggest that vasoactive intestinal peptide (VIP) binds to lymphocytes and modulates immune responses. The intestines are richly innervated with VIP-producing nerves. Thus, VIP from nerves or other sources may participate in mucosal immunoregulation. To explore this hypothesis further, murine intestinal mucosa inflammatory cells were scrutinized for functional VIP receptors. An [125I]VIP competitive binding assay characterized VIP receptors. Unfractionated lamina propria inflammatory cells bound [125I]VIP specifically. This binding was abrogated by T cell depletion. The VIP receptor on lamina propria T cells was of a single class with a Kd of 9.08 × 10−9 M. It bound PHI and other peptide analogs poorly. The intestinal epithelial cell had a high-affinity VIP receptor (Kd 4.17 × 10−10 M) that bound one VIP analog with moderate affinity. Both VIP and ConA stimulated mucosal inflammatory cells to release interleukin-5 (IL-5). Mucosal inflammatory cells depleted of T cells did not release IL-5 in response to VIP or ConA. It is concluded that: (1) some murine mucosal T lymphocytes have VIP receptors that may be distinct from those displayed on mucosal epithelial cells; (2) VIP affects mucosal T lymphocyte function.

References (30)

  • S.P. James et al.

    T cells in inductive and effector compartments of the intestinal mucosal immune system of nonhuman primates differ in lymphokine mRNA expression, lymphokine utilization, and regulatory function

    J. Immunol.

    (1990)
  • D.A. Lebman et al.

    The effect of IL-4 and IL-5 on the IgA response by murine Peyer's patch B cell subpopulations

    J. Immunol.

    (1988)
  • A.F. Lopez et al.

    Murine eosinophil differentiation factor: an eosinophilspecific colony-stimulating factor with activity for human cells

    J. Exp. Med.

    (1986)
  • L. Mayer et al.

    Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease

    J. Clin. Invest.

    (1990)
  • M.S. O'Dorisio

    Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous, endocrine, and immune systems

  • Cited by (35)

    • Target-specific delivery of peptide-based probes for PET imaging

      2010, Advanced Drug Delivery Reviews
      Citation Excerpt :

      Having an essential histidine (His) residue at the N terminus and an amidated C terminus, all 28 amino acids of VIP are required for full biologic activity [165,166]. The gene receptors VPAC1 and VPAC2 have been detected on the cell membrane of normal intestinal [167,168] and bronchial epithelial cells [168,169] and are overexpressed on various tumor cells, including colonic adenocarcinomas [168–172], pancreatic carcinoma [173], and carcinoids [167]. Because of the hypothesis that VIP labeled with a suitable radionuclide can serve as a tool for molecular imaging and noninvasive, early scintigraphic detection of malignant lesions, VIP has been labeled with 64Cu for PET imaging.

    • TCR signaling and environment affect vasoactive intestinal peptide receptor-1 (VPAC-1) expression in primary mouse CD4 T cells

      2008, Brain, Behavior, and Immunity
      Citation Excerpt :

      Immune cells that express VIP receptors in proximity to VIP positive nerve endings can respond to a “neuro-delivered” biologically active ligand (Delgado et al., 1996; Goetzl et al., 1998; Cozzi, 1999). VIP sources can also be non-neuronal as Th2, but not Th1, CD4 T cells synthesize and secrete VIP, acting in an autocrine or paracrine manner, to support the Th2 immune response (Blum et al., 1992; Delgado and Ganea, 1999; Goetzl et al., 2001; Voice et al., 2001; Delgado and Ganea, 2001; Vassiliou et al., 2001). The immunomodulatory actions of this “neuro-cytokine-like” ligand, VIP, on T cells has been demonstrated to act by suppressing the crucial T cell growth factor, IL-2, through a VPAC-1 signaling cAMP-dependent mechanism (Wang et al., 2000).

    • Neuromuscular regulation of T-cell activation

      1997, Journal of Neuroimmunology
    View all citing articles on Scopus
    View full text